What is BNR's revenue growth forecast for 2026-2026?
(NASDAQ: BNR) Burning Rock Biotech's forecast annual revenue growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Burning Rock Biotech's revenue in 2026 is $75,740,870.
In 2026, BNR is forecast to generate $123,040,755,314 in revenue, with the lowest revenue forecast at $119,377,545,436 and the highest revenue forecast at $127,889,121,329.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.